Genetic and Clinical Features of P450 Oxidoreductase Deficiency
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
P450 oxidoreductase (POR) deficiency is an autosomal recessive disorder of steroidogenesis with multiple clinical manifestations. POR is the electron donor for all microsomal P450 enzymes, including the three steroidogenic enzymes P450c17 (17α-hydroxylase/17,20-lyase), P450c21 (21-hydroxylase), and P450aro (aromatase). Since the first description of POR mutations in 2004, about 50 patients have been reported. Serum steroid profiles indicate partial deficiencies in 21-hydroxylase, 17α-hydroxylase and 17,20-lyase. The 17-OH progesterone levels are elevated, as in 21-hydroxylase deficiency, while androgen levels are low; cortisol may be normal but is poorly responsive to adrenocorticotropic hormone. Most patients also have associated skeletal malfor- mations (craniosynostosis, radio-ulnar synostosis, midface hypoplasia, bowed femora) termed Antley-Bixler syndrome. Antley-Bixler syndrome with normal steroidogenesis is caused by autosomal dominant gain-of-function mutations in fibroblast growth factor receptor 2. Males with POR deficiency are often undervirilized, while females can be virilized. The prognosis for patients with POR deficiency appears to depend on the severity of the bony malformations and their timely treatment. The potential impact of POR mutations on drug metabolism by other hepatic P450 enzymes requires further investigation. Given the varied physical and biochemical phenotype of POR deficiency and the risk of adrenal insufficiency, clinicians should be alert to this potential diagnosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50 POR mutations have now been described, affecting various P450 enzymes to differing degrees, apparently explaining the great variability in the clinical and hormonal findings in POR deficiency (305,319).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [319]
In the citing paper
“Despite its embryonic lethality in mice, POR deficiency is a newly recognized form of CAH (305, 314 -319).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [319]
In the citing paper
“The incidence of POR deficiency is unknown; the rapid description of large numbers of patients (305, 319) and the potentially very subtle clinical manifestations in individuals carrying mutations with partial activity (283,305,314,335) suggest that POR deficiency may be fairly common.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [319]
Citations
Cites
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome
Reardon, W., Winter, R. M., Rutland, P., Pulleyn, L. J., Jones, B. M., & Malcolm, S. (1994) · Nature Genetics · doi:10.1038/ng0994-98 · Cited by 758
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome
Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614 · cited 1×
“FGFs can bind four different tyrosine kinase cell surface receptors (FGFRs). Dominant gain-of-function mutations in FGFRs (primarily FGFR2) cause a number of phenotypically diverse craniosynostosis syndromes, including Pfeiffer, Apert, Jackson-Weiss, and Crouzon syndromes [”
BackgroundCytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509 · cited 1×
“and the recently described P450 oxidoreductase (POR) deficiency [”
BackgroundSelf-citationIdentical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes
Rutland, P., Pulleyn, L. J., Reardon, W., Baraitser, M., Hayward, R., Jones, B., Malcolm, S., Winter, R. M., Oldridge, M., Slaney, S. F., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-173 · Cited by 451
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Research works printed but not linked: 4
- 10.1074%2Fjbc.271.11.6483 · DOI · Paper page
- 10.1210%2Fme.13.1.167 · doi:10.1210/me.13.1.167 · Paper page
- 10.1097%2F00006454-199211120-00017 · DOI
- 10.1210%2Fme.13.7.1169 · doi:10.1210/me.13.7.1169 · Paper page
Cited by
Items 101–115 of 115
Disorders of sexual development
Winter, W. E., Hiers, P. S., & Greene, D. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818277-2.00016-9 · Cited by 1
A Rare Cause of Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency: a Case Report
Cınaz, P., Emeksiz, H. C., Çelik, N., Döğer, E., Yüce, Ö., Camurdan, O. M., & Bıdecı, A. (2014) · 53rd ESPE Meeting
Pediatric reproductive disorders
Josefson, J. L., & Haymond, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00016-0
Disorders of Adrenals and Gonads
Lauber-Biason, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-40337-8_37
Congenital Adrenal Hyperplasia
Trapp, C. M., Levine, L. S., & Oberfield, S. E. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_13
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832c937e
Primäre Nebenniereninsuffizienz bei Kindern und Jugendlichen
Kamrath, C., & Riepe, F. G. (2018) · Springer Reference Medizin · doi:10.1007/978-3-662-52794-8_34-1
Disorders of Adrenals and Gonads
Biason‐Lauber, A. (2022) · Springer eBooks · doi:10.1007/978-3-030-67727-5_55
Congenital Arenal Hyperplasia Due to P450 Oxidoreductase Deficiency
Asfour, H. (2023) · Springer eBooks · doi:10.1007/978-3-319-66816-1_1818-1
Shafqat, N., Amdani, S. N., & Ming, L. C. (2024) · Journal of Research in Pharmacy · doi:10.29228/jrp.718
Genetics of Congenital Adrenal Hyperplasia
Rao, S., & Walia, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-1639-5_29
46, XX DSD with Atypical Genitalia: Clinical Insights and Diagnostic Approaches
Karlekar, M. P., Sarathi, V., Barnabas, R., Lila, A. R., Memon, S. S., Shah, N. S., & Bandgar, T. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2538-3603
Tannour‐Louet, M., & Lamb, D. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_20
The pharmacogenetic of cyclosporine in Tunisian renal transplantation
Abderahmene, A., Moussa, A., SAHTOUT, W., Awatif, A., Ammar, M., Amor, D., Chouchène, S., Zellama, D., Bouslama, A., & omezzine, A. (2026) · Pharmacogenomics · doi:10.1080/14622416.2026.2718046
Metadata
- Authors
- Scott, R. R., & Miller, W. L.
- Affiliations
- Dalhousie University (CA)
- ORCID
- Miller, Walter L.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 69
- Issue
- 5
- Pages
- 266-275
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2060640171
- Semantic Scholar
- 4514e0eb72f2700a24f074ea036f7d8a59450a24
- Cited by
- 115
- References
- 61
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 3 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM073020, R01GM073020)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- P450 oxidoreductase deficiency, steroidogenesis, 21-hydroxylase deficiency, 17α-hydroxylase/17,20-lyase deficiency, aromatase deficiency, Antley-Bixler syndrome, FGFR2, craniosynostosis, adrenal insufficiency, sex reversal, drug metabolism, autosomal recessive disorder
- MeSH terms
- Abnormalities, Multiple, Bone and Bones, Cytochrome P-450 Enzyme System, Endocrine System Diseases, Humans, Hydroxysteroid Dehydrogenases, Models, Biological, NADH, NADPH Oxidoreductases, Steroid 17-alpha-Hydroxylase, Steroid 21-Hydroxylase, Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.